What actually changed on April 28, 2026
The final rule took effect immediately on publication. It was issued under a treaty-obligation authority (21 U.S.C. 811(d)(1)), which let DEA act without completing the full notice-and-comment process that the broader rescheduling proposal is still going through. The rule's text is explicit: any form of marijuana other than an FDA-approved drug product or marijuana subject to a state medical marijuana license remains a Schedule I controlled substance.
The broader proposal to move all marijuana to Schedule III (proposed May 2024, 89 FR 44597) is still alive — DEA scheduled new hearings beginning June 29, 2026. Until that concludes, the United States runs a two-track system: medical cannabis dispensed under state licenses sits in Schedule III; everything else sits in Schedule I.
What it means for patients
For day-to-day patient life, less changed than headlines suggested. State program rules — cards, physician certifications, purchase limits — operate exactly as before; rescheduling didn't federalize or replace state programs. What changed is the federal legal posture of state-licensed medical cannabis: Schedule III substances are recognized as having accepted medical use, which strengthens research access and removes the punitive IRC 280E tax treatment from state-licensed dispensaries (which may eventually show up in prices).
What did NOT change yet: downstream federal agencies. ATF has not updated its firearms guidance, the IRS has not updated Publication 502 (so HSA/FSA funds still can't pay for cannabis), and DOT drug-testing rules for CDL drivers still treat THC as disqualifying. Interstate transport also remains illegal — the rule simultaneously amended import/export regulations so that even Schedule III marijuana requires DEA permits individual patients can't obtain.
Why getting a card matters more after rescheduling
The two-track system created a meaningful legal distinction between the same plant bought through a state medical program and bought anywhere else. With a state license behind it, your cannabis is a Schedule III substance; without one, it's Schedule I. That's the strongest legal argument for holding a valid medical card since state programs began.
The information on this site is for educational purposes only and is not medical or legal advice. Cannabis use carries risks; consult a licensed physician about whether medical cannabis is appropriate for you. Federal status (as of June 2026): marijuana dispensed under state medical licenses and FDA-approved cannabis products are Schedule III controlled substances; all other marijuana remains Schedule I under U.S. federal law. Laws cited here change; confirm current rules with the linked primary sources before acting on them.